Nabla Bio
MA - CambridgeBiotechnology
Focus: Nabla Bio is an antibody design-focused biotechnology company based in Cambridge, MA, specializing in oncology therapeutics. The company appears to be in early-stage development with a nascent pipeline and emerging commercial infrastructure.
Profile data last refreshed 4h ago · AI intelligence enriched 1w ago
Open Jobs
9-9 this month
Cooling — net -9 jobs in 30d
5 added, 14 removed. Slower than typical.
Should You Work at Nabla Bio?
AI assessmentBest suited for early-stage risk-tolerant candidates seeking to build oncology antibody science in a lean startup environment, not those prioritizing stability or near-term commercial success.
Why Work Here
- Opportunity to build from the ground up in a focused antibody platform company with oncology focus in a premier biotech hub (Cambridge)
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Nabla Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.